Status | Study |
Completed |
Study Name: Detraining in People Living With HIV/AIDS Condition: Lipodystrophy Syndrome, HIV Sarcopenia Date: 2017-02-09 Interventions: Other: combined training Combined training consisting of aerobic and resisted training in the same train |
Completed |
Study Name: Energy Expenditure of People Living With HIV/AIDS Condition: HIV/AIDS HIV Lipodystrophy Syndrome Date: 2015-08-04 Interventions: Drug: use of lipid-lowering drugs. The patients shoud be in use of a lipid-lowering drugs previouly, at |
Completed |
Study Name: An Study to Investigate the Recovery, Excretion, and Pharmacokinetics of 14C-GSK1265744 Administered as a Single Oral Dose and a Study to Describe the Pharmacokinetics of a Supratherapeutic Dose of GSK1265744 in Healthy Adult Subjects Condition: HIV-associated Lipodystrophy Syndrome Date: 2013-05-02 Interventions: Drug: GSK1265744B (sodium salt) containing 14C-GSK1265744B |
Completed |
Study Name: Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy Syndrome Condition: HIV Lipodystrophy Date: 2012-01-11 Interventions: Drug: Human recombinant leptin ("metreleptin") |
Completed |
Study Name: Psychological Morbidity and Facial Volume in HIV Lipodystrophy: Quantification of Treatment Outcome Condition: HIV-Associated Lipodystrophy Syndrome Date: 2011-05-23 |
Completed |
Study Name: Polyacrylamide Hydrogel Injection in HIV-related Lipoatrophy Condition: HIV Infection Antiretroviral Side Effects Lipodystrophy Sy Date: 2010-02-26 Interventions: Device: Eutrophill Polyacrylamide Hydrogel |
Terminated |
Study Name: Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone Condition: HIV Infections HIV-Associated Lipodystrophy Syndrome Date: 2008-04-16 |
Completed |
Study Name: Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy Condition: HIV-Associated Lipodystrophy Syndrome Date: 2008-03-26 Interventions: Drug: Standard continuous antiretroviral therapy |
Completed |
Study Name: TH9507 Extension Study in Patients With HIV- Associated Lipodystrophy Condition: Lipodystrophy HIV Infections Date: 2008-01-23 Interventions: Drug: Tesamorelin Other Name: |
Completed |
Study Name: Therapeutic Approaches to HAART-Induced Lipodystrophy Condition: HIV Infections Lipodystrophy Date: 2007-04-16 Interventions: Drug: Metreleptin (Leptin) weight based, sub-cutaneous injection, twice daily |